J. Lenkiewicz, “THE SIGNIFICANCE OF THE BCR::ABL1 BIOMARKER IN THE DIAGNOSIS AND TREATMENT MONITORING OF CHRONIC MYELOID LEUKEMIA: A NARRATIVE REVIEW”, IJITSS, vol. 3, no. 3(51), Sep. 2026, doi: 10.31435/ijitss.3(51).2026.6488.